The total turnover of the pharmaceutical industry reached 1.44 trillion dollars (2300 largest global producers), of which 555 billion dollars fell to the United States. Experts list Japan, Germany, China, France, Switzerland and Britain as the other biggest markets.
The places in the ranking are distributed as follows*:
- Johnson & Johnson (USA, New Brunswick) — $ 93,78 billion;
- Pfizer (USA, New York) — $ 81,29 billion;
- Sinopharm (China, Beijing) — $ 77,28 billion;
- Roche Holding (Switzerland, Basel) — $69,01 billion;
- AbbVie (USA, Chicago) — $56,20 billion;
- Novartis (Switzerland, Basel) — $52,88 billion;
- Bayer (Germany, Leverkusen) — $50,09 billion ;
- Merck & Co. (USA, New Jersey) — $48,70 billion;
- Bristol Myers Squibb (USA, New York) — $46,39 billion;
- GlaxoSmithKline (UK, Brentford) — $46,10 billion;
- Sanofi (France, Paris) — $44,52 billion;
- Abbott Laboratories (USA, Illinois) — $43,08 milyard;
- AstraZeneca (UK, Cambridge) — $37,42 billion;
- Shanghai Pharmaceuticals (China, Shanghai) — $29,43 billion ;
- Takeda Pharmaceutical (Japan, Tokyo) — $29,10 billion.
* Market capitalization is based on pharmaceutical company financial reports, Reuters data and The Pharma 1000: Top Global Pharmaceutical Company Report.
Source: https://lindeal.com/trends/top-15-uspeshnykh-farmacevticheskikh-kompanij-mira
